Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced ...

Using cryo-electron microscopy technologies, Serianni and Škerlová et al. reveal how Np n Ns initiate bacterial transcription as noncanonical RNA caps by showing one nucleobase pairing with the ...

With sunny weather most of the year, lunch is appropriately a verb in Los Angeles. Midday meetups with friends and colleagues are always better when tables are full of salads, ceviche, burgers, and ...